Champions Oncology (CSBR) Current Leases (2018 - 2026)
Champions Oncology (CSBR) posted quarterly Current Leases of $1.5 million for Q2 2026, up 3.33% year-over-year from $1.5 million in Q2 2025, and down 0.59% quarter-over-quarter from $1.5 million in Q1 2026.
Champions Oncology (CSBR) Current Leases (2018 - 2026) Analysis & Trends
Champions Oncology's Current Leases history runs 9 years deep, the most recent figure standing at $1.5 million for Q2 2026.
- In Q2 2026, Current Leases rose 3.33% year-over-year to $1.5 million; the TTM figure through Apr 2026 stood at $1.5 million (up 3.33% YoY), while the FY2026 annual figure was $1.5 million, up 3.33% from the prior year.
- Current Leases for Q2 2026 stood at $1.5 million, down from $1.5 million in the prior quarter.
- The five-year high for Current Leases was $1.5 million in Q1 2026, with the low at $1.0 million in Q1 2022.
- The 5-year median for Current Leases is $1.3 million (2024), against an average of $1.3 million.
- The sharpest annual moves came in 2022 and 2026: Current Leases soared 61.46% in 2022, then rose 3.33% in 2026.
- Champions Oncology's Current Leases stood at $1.1 million in 2022, then advanced by 12.53% to $1.3 million in 2023, then gained by 9.88% to $1.4 million in 2024, then increased by 8.85% to $1.5 million in 2025, then decreased by 0.33% to $1.5 million in 2026.
- Business Quant data shows CSBR's Current Leases at $1.5 million in Q2 2026, $1.5 million in Q1 2026, and $1.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 1.52 Mn |
| Jan 31, 2026 | 1.53 Mn |
| Oct 31, 2025 | 1.53 Mn |
| Jul 31, 2025 | 1.51 Mn |
| Apr 30, 2025 | 1.47 Mn |
| Jan 31, 2025 | 1.43 Mn |
| Oct 31, 2024 | 1.40 Mn |
| Jul 31, 2024 | 1.37 Mn |
| Apr 30, 2024 | 1.34 Mn |
| Jan 31, 2024 | 1.31 Mn |
| Oct 31, 2023 | 1.28 Mn |
| Jul 31, 2023 | 1.24 Mn |
| Apr 30, 2023 | 1.21 Mn |
| Jan 31, 2023 | 1.17 Mn |
| Oct 31, 2022 | 1.13 Mn |
| Jul 31, 2022 | 1.10 Mn |
| Apr 30, 2022 | 1.05 Mn |
| Jan 31, 2022 | 1.01 Mn |
| Oct 31, 2021 | 930,000.00 |
| Jul 31, 2021 | 854,000.00 |